Showing results (11-20 of 82) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|July 14, 2012
Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover studyJoseph A Boscia, Krishna K Pudi, Michael T Zvarich, et al.
Current Medical Research and Opinion|April 2, 2015
Efficacy and safety of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg; 200/25 mcg) in Asian patients with chronic obstructive pulmonary disease: a randomized placebo-controlled trialJinping Zheng, Teresita de Guia, Jie Wang-Jairaj, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 22, 2004
Effect of fluticasone propionate and salmeterol in a single device, fluticasone propionate, and montelukast on overall asthma control, exacerbations, and costsRichard D O'Connor, Richard Stanford, Courtney Crim, et al.
International Journal of Chronic Obstructive Pulmonary Disease|February 2, 2018
Predictors of pneumonia on routine chest radiographs in patients with COPD: a post hoc analysis of two 1-year randomized controlled trialsDavid B Rubin, Harris A Ahmad, Michael O'Neal, et al.
BMC Pulmonary Medicine|May 6, 2020
A randomized, controlled, repeat-dose study of batefenterol/fluticasone furoate compared with placebo in the treatment of COPDCourtney Crim, Mark Gotfried, Selwyn Spangenthal, et al.
International Journal of Chronic Obstructive Pulmonary Disease|January 15, 2021
Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial StiffnessBenjamin D Horne, Rehan Ali, Dawn Midwinter, et al.
ATS Scholar|March 28, 2026
ATS BEAR Cage: 10 Years of Building Education to Advance Research with Innovation, Competition, & FunJason P Kirkness, Dayna Howell, Vlada K O'Hara, et al.
Respiratory Research|May 10, 2019
Association of platelet count with all-cause mortality and risk of cardiovascular and respiratory morbidity in stable COPDAshraf Fawzy, Julie A Anderson, Nicholas J Cowans, et al.
Journal of the National Medical Association|October 18, 2008
A new focus on assessing and treating asthma control in the African-American community: a call to actionMichael Lenoir, Cheryl Lynn Walker McGill, Leroy M Graham, et al.
Respiratory Medicine|April 13, 2011
Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline resultsCourtney Crim, Bartolome Celli, Lisa D Edwards, et al.
Pageof 9